Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC Meeting Abstract


Authors: Kim, H. K.; An, J. A. R.; Smith, C. G.; Kim, J.; Cabel, L.; Moiso, E.; Ferraro, E.; Safonov, A.; Nelson, K.; Szuhany, K.; Drago, J. Z.; Norton, L.; Xu, A.; Scher, H. I.; Chandarlapaty, S.; Khan, A. J.; Li, B. T.; Robson, M. E.; Plitas, G.; Razavi, P.
Abstract Title: Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557400654
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.3049
Notes: Meeting Abstract: 3049 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Larry Norton
    762 Norton
  2. Mark E Robson
    684 Robson
  3. George Plitas
    108 Plitas
  4. Howard Scher
    1133 Scher
  5. Pedram Razavi
    184 Razavi
  6. Bob Tingkan Li
    279 Li
  7. Amy Jia Xu
    67 Xu
  8. Atif Jalees Khan
    160 Khan
  9. Joshua Drago
    31 Drago
  10. Emanuela Ferraro
    33 Ferraro
  11. Anton Safonov
    36 Safonov
  12. Enrico Moiso
    10 Moiso
  13. Luc Cabel
    7 Cabel
  14. Ah Reum An
    7 An
  15. Hong Kyu Kim
    1 Kim
  16. Konner Nelson
    1 Nelson